Media Thread, page-14142

Leading shareholders are fed up with the media and marketing strategy employed by Imugene over the years. What do they say, if you keep doing the same thing you'll get the same results. Imugene (IMU ASX) has been successful at chasing leading medical conferences, but on the media front has been pathetic in hocking their wares around small to mid cap presentations in down town Australia. Heaven forbid by the look of it they have now regressed into presenting at startup and venture capital meetings. Seriously, who is running and advising this company from a communications and media perspective? You have multi billion dollar scientifically significant platforms designed to kill "any type of cancer" that has produced "significant tumour killing" in many instances across the board, and your speaking with a bunch of start up and VC investors in Australia!

Meanwhile back home on the Ranch the Biotech industry in the US and less advanced stocks are spruiking their wares on the Nasdaq at higher highs to more and more institutions and healthcare players. I seriously give up. It's time for shareholders to stand up and put an end to this miserable existence from a media, market and communications perspective. Before you know it Leslie shall be presenting to a bunch of retirees at Blacktown RSL and IMU shall be worth $400m AUD at the same time as direct competitors such as CG Oncology https://www.nasdaq.com/market-activity/stocks/cgon are hitting market caps of $4Bn AUD. Help me out, what's next? What is going to take this company to finally stop digging bigger holes for themselves and start positioning themselves where they need to be in the market.

Ditch Bell Potter and your media consultants. Employ a healthcare marketing specialist and contract one or two leading US biotech influencers. Align with a leading US broker to engage in a Nasdaq listing. Oh and btw don't give me the BS sprouted by Hopper, (the guy has pulled every wrong market reign with IMU known to man in recent years) ... that's right, the BS that we need to do this listing and that at the right time..
You say you have the science.....You say you're excited about it.....Nothing happens unless you make it....Just get on with it.....

Stop talking science to the public and start talking dollars and sense, the stuff investors want to hear. And take a note out of Albert Einstein's book
One definition of insanity is "doing the same thing over and over and expecting different results."

Oh and while you're their show some backbone and get rid of Shah and the rest of your business team officianado's and outsource the licensing of your B cell platform to a team in the US with M&A experience, as opposed to mid tier clinical trial and procedural experience. Take some of your overpaid and underperforming directors with them and appoint some US directors who large players actually recognise, follow and support in the US, like I told you to do over two years ago now. Ex Big Pharma would suit. Put some led in your pencil and grow a spine by appointing a leading US figure as your Chairperson prior to listing while you're there. One who has the respect, support and resume to compliment a company of your pre eminent medical stature.

Opinion Only